# FDA Inspection 1302518 - Enemeez, LLC dba Summit Pharmaceuticals - February 12, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/12a25bf5-77ce-4384-a93c-ff5f6e98e524
Source feed: FDA_Inspections

> FDA Inspection 1302518 for Enemeez, LLC dba Summit Pharmaceuticals on February 12, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302518
- Company Name: Enemeez, LLC dba Summit Pharmaceuticals
- Inspection Date: 2026-02-12
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Denver District Office

## Related Documents

- [FDA Inspection 1147428 - 2021-07-29](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/7e7bbba6-611e-4478-a3de-f582c1b59bd4)
- [FDA Inspection 987440 - 2016-08-10](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/dc80d110-051f-497b-9582-53e15040cdf4)
- [FDA Inspection 728243 - 2011-06-06](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/992c79ea-0e09-490a-9175-027babbc7ae1)
- [FDA Inspection 656042 - 2010-03-12](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/956789fb-e51c-4fc8-9706-d3394939db6e)

Company: https://www.globalkeysolutions.net/companies/enemeez-llc-dba-summit-pharmaceuticals/dd1473a2-9b40-4ff6-a713-f83d1ba98c4f

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face